CA Patent

CA3247772A1 — Spirocyclic piperidinyl derivatives as complement factor b inhibitors and uses thereof

Assigned to Novartis AG · Expires 2023-07-27 · 3y expired

What this patent protects

"Compounds of formula (I) and pharmaceutical compositions thereof are described that are useful for the treatment of diseases or disorders mediated by complement factor B (I)."

USPTO Abstract

"Compounds of formula (I) and pharmaceutical compositions thereof are described that are useful for the treatment of diseases or disorders mediated by complement factor B (I)."

Drugs covered by this patent

Patent Metadata

Patent number
CA3247772A1
Jurisdiction
CA
Classification
—
Expires
2023-07-27
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.